NCT01009073 2017-11-20A Study Evaluating ABT-263 With Erlotinib, ABT-263 With Irinotecan, and ABT-263 Monotherapy in Cancer SubjectsAbbViePhase 1 Completed51 enrolled
NCT00770263 2015-06-03Erlotinib and Temsirolimus for Solid TumorsWashington University School of MedicinePhase 1 Completed46 enrolled
NCT00495872 2012-10-18Valproic Acid-Based 2-Agent Oral Regimens for Patients With Advanced Solid TumorM.D. Anderson Cancer CenterPhase 1 Completed204 enrolled